title: Metabolic syndrome: screening, diagnosis, and management.
abstract: Metabolic syndrome, a growing issue in women's health, is a cluster of health findings that increase the risk of cardiovascular events. The prevalence of metabolic syndrome is higher in women and is linked to several conditions unique to women's health, including polycystic ovary syndrome, gestational diabetes, pregnancy-induced hypertension, and female sexual dysfunction. Risk factors, screening strategies, and therapeutic management of metabolic syndrome in women are discussed.
authors.affiliation: elissa.miller@midwives.org
authors.forename: Elissa Lane
authors.initials: EL
authors.lastname: Miller
authors.forename: Angela
authors.initials: A
authors.lastname: Mitchell
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001521:Behavior Therapy / Q000379:methods; D015992:Body Mass Index; D015897:Comorbidity; D016640:Diabetes, Gestational / Q000453:epidemiology; D050171:Dyslipidemias / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008019:Life Style; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009765:Obesity / Q000175:diagnosis; D011247:Pregnancy; D015995:Prevalence; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents